[
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions",
    "summary": "Medical device leaders counter tariff pressures with innovation, as AI adoption and aging demographics support long-term growth.",
    "url": "https://finnhub.io/api/news?id=074ef44b244ed393a78b855792b4046a0d6f9db9ccf81ba909a3e639cd7c440c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770138120,
      "headline": "Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions",
      "id": 138345652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Medical device leaders counter tariff pressures with innovation, as AI adoption and aging demographics support long-term growth.",
      "url": "https://finnhub.io/api/news?id=074ef44b244ed393a78b855792b4046a0d6f9db9ccf81ba909a3e639cd7c440c"
    }
  },
  {
    "ts": null,
    "headline": "Here’s What Hit Baxter (BAX) in Q4",
    "summary": "Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The fourth quarter was defined by strong AI momentum and continued market dominance by mega-cap stocks. In this environment, Pzena Focused Value Strategy underperformed the Russell 1000® Value Index, delivering a net return of […]",
    "url": "https://finnhub.io/api/news?id=f99f50be1a2a625f96c3b110e5ec5ac5e81d50581478d1997a87215f4d3b2a29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770122982,
      "headline": "Here’s What Hit Baxter (BAX) in Q4",
      "id": 138341957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The fourth quarter was defined by strong AI momentum and continued market dominance by mega-cap stocks. In this environment, Pzena Focused Value Strategy underperformed the Russell 1000® Value Index, delivering a net return of […]",
      "url": "https://finnhub.io/api/news?id=f99f50be1a2a625f96c3b110e5ec5ac5e81d50581478d1997a87215f4d3b2a29"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Product Stocks to Watch From a Challenging Industry (Revised)",
    "summary": "The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
    "url": "https://finnhub.io/api/news?id=6a5cb66c5afe5a21fb02f8dd0209293dfd7f880330f8a8712ba4e78d03be9d7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770115020,
      "headline": "4 Medical Product Stocks to Watch From a Challenging Industry (Revised)",
      "id": 138340783,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
      "url": "https://finnhub.io/api/news?id=6a5cb66c5afe5a21fb02f8dd0209293dfd7f880330f8a8712ba4e78d03be9d7a"
    }
  }
]